Silver Book Fact

Delaying the onset of Alzheimer’s by only 5 years could reduce the number of people with Alzheimer’s by almost 50% after 50 years.

Brookmeyer, Ronald, Sarah M. Gray, and Claudia H. Kawas. Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset. Am J Public Health. 1998; 88(9): 1337-42. http://www.ajph.org/cgi/content/abstract/88/9/1337?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=brookmeyer&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT

Reference

Title
Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset
Publication
Am J Public Health
Publication Date
1998
Authors
Brookmeyer, Ronald, Sarah M. Gray, and Claudia H. Kawas
Volume & Issue
Volume 88, Issue 9
Pages
1337-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, because of medical research, the number of Americans with Alzheimer’s could decrease by 3 million in 2025.  
  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • The U.S. Food and Drug Administration has approved 5 drugs for the treatment of Alzheimer’s disease. These drugs have been found to temporarily slow the worsening of Alzheimer’s symptoms for…  
  • “If you or a loved one started exhibiting symptoms of Alzheimer’s disease 12 years ago, there were no medicines for you to take. All you could do was hope–that…  
  • Around 75 – 100 experimental therapies that are aimed at slowing or stopping the progression of Alzheimer’s disease are currently in clinical trials.